The treatment of hip fractures: Variations in care

Clinical Orthopaedics and Related Research

Volumn 442, Issue , 2006, Pages 239-244

  Lieberman, Jay R ^a,e   Romano, Patrick S ^b,d   Mahendra, Geeta ^c,d   Keyzer, Janet ^c,d   Chilcott, Marisha ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHS 76 134   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AGED; ANTIBIOTIC THERAPY; ARTHROPLASTY; ARTICLE; BIPOLAR HEMIARTHROPLASTY; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; ELDERLY CARE; FEMALE; FOLLOW UP; HIP FRACTURE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; UNITED STATES; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; EPIDEMIOLOGY; HIP ARTHROPLASTY; METHODOLOGY; MORTALITY; STATISTICAL MODEL; STATISTICS; VEIN THROMBOSIS;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; CALIFORNIA; CHI-SQUARE DISTRIBUTION; FEMALE; HIP FRACTURES; HUMANS; LOGISTIC MODELS; MALE; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SAMPLING STUDIES; VENOUS THROMBOSIS;

EID: 33645092949     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000188558.67172.4e     Document Type: Article

References (29)

1. Agnelli G, Cosmi B, Di Filippo P, Ranucci V, Veschi F, Longetti M, Renga C, Barzi F, Gianese F, Lupattelli L, et al. A randomised double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost. 67:203-208, 1992.
2. Baumgaertner MR, Curtin SL, Lindskog DM. Intramedullary versus extramedullary fixation for the treatment of intertrochenteric hip fractures. Clin Orthop Relat Res. 1998;348:87-94.
3. Bhandari M, Devereaux PJ, Swiontkowski MF, Tornetta P 3rd, Obremsky W, Koval KJ, Nork S, Sprague S, Schemitsch EH, Guyatt GH. Internal fixation compared with arthroplasty for displaced fractures of the femoral neck: a meta-analysis. J Bone Joint Surg Am. 2003;85:1673-1681.
4. Bhattacharyya T, Iorio R, Healy WL. Rate of and risk factors for acute inpatient mortality after orthopaedic surgery. J Bone Joint Surg Am. 2002;84:562-572.
5. Carter GM. A Risk Adjusted Model for Mortality Following Surgery for Hip Fracture. Los Angeles, CA: RAND; 1998.
6. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353:878-882.
7. Clagett GP, Anderson Jr FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest. 1995;108(4 suppl):312S-334S.
8. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ 3rd. Population- based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137:1001-1005.
9. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761-1767.
10. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB. Prevention of venous thromboembolism. Chest. 2001;119(1 suppl):132S-175S.
11. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):338S-400S.
12. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407-413.
13. Hamlet WP, Lieberman JR, Freedman EL, Dorey F, Fletcher A, Johnson EE. Influence of health status and the timing of surgery on mortality in hip fracture patients. Am J Orthop. 1997;26:621-627.
14. Huusko TM, Karppi P, Avikainen V, Kautiainen H, Sulkava R. The changing picture of hip fractures: dramatic change in age distribution and no change in age-adjusted incidence within 10 years in Central Finland. Bone. 1999;24:257-259.
15. International Classification of Diseases, 9th Revision, Clinical Modification Rich text files available at: http://www.ced.gov/nchs/icd9.htm#RTF. Accessed August 3, 2005.
16. Koval KJ, Aharonoff GB, Rosenberg AD, Bernstein RL, Zuckerman JD. Functional outcome after hip fracture: effect of general versus regional anesthesia. Clin Orthop Relat Res. 1998;348:37-41.
17. Kyle RF, Cabanela ME, Russell TA, Swiontkowski MF, Winquist RA, Zuckerman JD, Schmidt AH, Koval KJ. Fractures of the proximal part of the femur. Instr Course Lect. 1995;44:227-253.
18. Lieberman JR, Geerts WH. Prevention of venous thromboembolism after total hip and knee arthroplasty. J Bone Joint Surg Am. 1994;76:1239-1250.
19. Miller CW. Survival and ambulation following hip fracture. J Bone Joint Surg Am. 1978;60:930-934.
20. Ong BC, Maurer SG, Aharonoff GB, Zuckerman JD, Koval KJ. Unipolar versus bipolar hemiarthroplasty: functional outcome after femoral neck fracture at a minimum of thirty-six months of follow-up. J Orthop Trauma. 2002;16:317-322.
21. Parker MJ, Blundell C. Choice of implant for internal fixation of femoral neck fractures: meta-analysis of 25 randomised trials including 4,925 patients. Acta Orthop Scand, 1998;69:138-143.
22. Poor G, Atkinson EJ, O'Fallon WM, Melton LJ 3rd. Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res. 1995;319:260-265.
23. Praemer A, Fumer S, Rice DP. Musculoskeletal Conditions in the United States. Park Ridge, IL: American Academy of Orthopaedic Surgeons; 1992.
24. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295-1301.
25. Ray NF, Chan JK, Thamer M, Melton LJ 3rd. Medical expenditures for the treatment of osteoporosis fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:24-35.
26. Swiontkowski MF. Intracapsular fractures of the hip. J Bone Joint Surg Am. 1994;76:129-138.
27. Southwell-Keely JP, Russo RR, March L, Cumming R, Cameron I, Brnabic AJ. Antibiotic prophylaxis in hip fracture surgery: a metaanalysis. Clin Orthop Relat Res. 2004;419:79-84.
28. Thonse R, Sreenivas M, Sherman KP. Timing of antibiotic prophylaxis in surgery for adult hip fracture. Ann R Coll Surg Engl. 2004;86:263-266.
29. Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, Parker MJ, Payne BV, Rushton N. Differences in mortality after fracture of the hip: the east Anglian audit. BMJ. 1995;310:904-908.